Vaspin can not inhibit TNF-α-induced inflammation of human umbilical vein endothelial cells

Journal of Veterinary Medical Science

Volumn 71, Issue 9, 2009, Pages 1201-1207

  Fu, Ben Dong ^a,b   Yamawaki, Hideyuki ^a   Okada, Muneyoshi ^a   Hara, Yukio ^a  

^a KITASATO UNIVERSITY   (Japan)

^b JILIN UNIVERSITY   (China)

Author keywords

Adipokine; Endothelial cell; Inflammation; Signal transduction

Indexed keywords

PROTEIN KINASE B; SERINE PROTEINASE INHIBITOR; SERPINA12 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; METABOLISM; UMBILICAL VEIN;

CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; PROTO-ONCOGENE PROTEINS C-AKT; SERPINS; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

RATTUS;

EID: 70349980165     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.71.1201     Document Type: Article

References (38)

1. Ahmed, R. A., Murao, K., Imachi, H., Yoshida, K., Dobashi, H., Hosomi, N. and Ishida, T. 2009. c-Jun N-terminal kinases inhibitor suppresses the TNF-alpha induced MCP-1 expression in human umbilical vein endothelial cells. Endocrine 35: 184-188.
2. Aust, G., Richter, O., Rohm, S., Kerner, C., Hauss, J., Klöting, N., Ruschke, K., Kovacs, P., Youn, B. S. and Blüher, M. 2009. Vaspin serum concentrations in patients with carotid stenosis. Atherosclerosis 204: 262-266.
3. Avogaro, A. and de Kreutzenberg, S.V. 2005. Mechanisms of endothelial dysfunction in obesity. Clin. Chim. Acta. 360: 9-26.
4. Baden, T., Yamawaki, H., Saito, K., Mukohda, M., Okada, M. and Hara, Y. 2008. Telmisartan inhibits methylglyoxal-mediated cell death in human vascular endothelium. Biochem. Biophys. Res. Commun. 373: 253-257.
5. Berg, A. H., Combs, T. P. and Scherer, P.E. 2002. ACRP30/ adiponectin: an adipokine regulating glucose and lipid metabolism. Trends. Endocrinol. Metab. 13: 84-89.
6. Chen, M. L., Xu, P. Z., Peng, X. D., Chen, W. S., Guzman, G., Yang, X., Di Cristofano, A., Pandolfi, P. P. and Hay, N. 2006. The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/- mice. Genes. Dev. 20: 1569-1574.
7. Crowell, J. A., Steele, V. E. and Fay, J. R. 2007. Targeting the AKT protein kinase for cancer chemoprevention. Mol. Cancer. Ther. 6: 2139-2148.
8. Fantuzzi, G. and Mazzone, T. 2007. Adipose tissue and atherosclerosis: exploring the connection. Arterioscler. Thromb. Vasc. Biol. 27: 996-1003.
9. Flier, J.S. 2004. Obesity wars: molecular progress confronts an expanding epidemic. Cell 116: 337-350.
10. Gulcelik, N. E., Karakaya, J., Gedik, A., Usman, A. and Gurlek, A. 2009. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur. J. Endocrinol. 160: 65-70.
11. Hida, K., Wada, J., Eguchi, J., Zhang, H., Baba, M., Seida, A., Hashimoto, I., Okada, T., Yasuhara, A., Nakatsuka, A., Shikata, K., Hourai, S., Futami, J., Watanabe, E., Matsuki, Y., Hiramatsu, R., Akagi, S., Makino, H. and Kanwar, Y. S. 2005. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc. Natl. Acad. Sci. U. S. A. 102: 10610-10615.
12. Hölschermann, H., Schuster, D., Parviz, B., Haberbosch, W., Tillmanns, H. and Muth, H. 2006. Statins prevent NF-kappaB transactivation independently of the IKK-pathway in human endothelial cells. Atherosclerosis 185: 240-245.
13. Hu, Y., Kiely, J. M., Szente, B. E., Rosenzweig, A. and Gimbrone, M.A. Jr. 2000. E-selectin-dependent signaling via the mitogen-activated protein kinase pathway in vascular endothelial cells. J. Immunol. 165: 2142-2148.
14. Joslin, G., Wittwer, A., Adams, S., Tollefsen, D. M., August, A. and Perlmutter, D. H. 1993. Cross-competition for binding of alpha 1-antitrypsin (alpha 1 AT)-elastase complexes to the serpin-enzyme complex receptor by other serpin-enzyme complexes and by proteolytically modified alpha 1 AT. J. Biol. Chem. 268: 1886-1893.
15. Karin, M. and Delhase, M. 2000. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin. Immunol. 12: 85-98.
16. Ke, J., Long, X., Liu, Y., Zhang, Y. F., Li, J., Fang, W. and Meng, Q. G. 2007. Role of NF-kappaB in TNF-alpha-induced COX-2 expression in synovial fibroblasts from human TMJ. J. Dent. Res. 86: 363-367.
17. Kishida, M., Urakaze, M., Takata, M., Nobata, Y., Yamamoto, N., Temaru, R., Sato, A., Yamazaki, K., Nakamura, N. and Kobayashi, M. 2005. PGE1 inhibits the expression of PAI-1 mRNA induced by TNF-alpha in human mesangial cells. Exp. Clin. Endocrinol. Diabetes 113: 365-371.
18. Klöting, N., Berndt, J., Kralisch, S., Kovacs, P., Fasshauer, M., Schon, M. R., Stumvoll, M. and Blïher, M. 2006. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem. Biophys. Res. Commun. 339: 430-436.
19. Lago, F., Dieguez, C., Gómez-Reino, J. and Gualillo, O. 2007. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev. 18: 313-325.
20. Li, Q., Chen, R., Moriya, J., Yamakawa, J., Sumino, H., Kanda, T. and Takahashi, T. 2008. A novel adipocytokine, visceral adipose tissue-derived serine protease inhibitor (vaspin), and obesity. J. Int. Med. Res. 36: 625-629.
21. Liu, X., Shi, Y., Giranda, V. L. and Luo, Y. 2006. Inhibition of the phosphotidylinositol 3-kinase/Akt pathway sensitizes MDA-MB468 human breast cancer cells to cerulenin-induced apoptosis. Mol. Cancer Ther. 5: 494-501.
22. McIlroy, M., O'Rourke, M., McKeown, S. R., Hirst, D. G. and Robson T. 2006. Pericytes influence endothelial cell growth characteristics: role of plasminogen activator inhibitor type 1 (PAI-1). Cardiovasc. Res. 69: 207-217.
23. McKenzie, S., Sakamoto, S. and Kyprianou, N. 2008. Maspin modulates prostate cancer cell apoptotic and angiogenic response to hypoxia via targeting AKT. Oncogene 27: 7171-7179.
24. Ronti, T., Lupattelli, G. and Mannarino, E. 2006. The endocrine function of adipose tissue: an update. Clin. Endocrinol. (Oxf) 64: 355-365.
25. Seeger, J., Ziegelmeier, M., Bachmann, A., Lössner, U., Kratzsch, J., Blüher, M., Stumvoll, M. and Fasshauer, M. 2008. Serum Levels of the Adipokine Vaspinin Relation to Metabolic and Renal Parameters. J. Clin. Endocrinol. Metab. 93: 247-251.
26. Shankar, S. S. and Steinberg, H.O. 2005. Obesity and endothelial dysfunction. Semin. Vasc. Med. 5: 56-64.
27. Shimomura, I., Funahashi, T., Takahashi, M., Maeda, K., Kotani, K., Nakamura, T., Yamashita, S., Miura, M., Fukuda, Y., Takemura, K., Tokunaga, K. and Matsuzawa, Y. 1996. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat. Med. 2: 800-803.
28. Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S. and Lazar, M. A. 2001. The hormone resistin links obesity to diabetes. Nature 409: 307-312.
29. Tan, B. K., Heutling, D., Chen, J., Farhatullah, S., Adya, R., Keay, S. D., Kennedy, C. R., Lehnert, H. and Randeva, H. S. 2008. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 57: 1501-1507.
30. Van Harmelen, V., Reynisdottir, S., Eriksson, P., Thörne, A., Hoffstedt, J., Lönnqvist, F. and Arner, P. 1998. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 47: 913-917.
31. Wozniak, S. E., Gee, L. L., Wachtel, M. S. and Frezza, E. E. Adipose Tissue: The New Endocrine Organ? A Review Article. Dig. Dis. Sci. in press.
32. Yamawaki, H. and Hara, Y. 2008. Glyoxal causes inflammatory injury in human vascular endothelial cells. Biochem. Biophys. Res. Commun. 369: 1155-1159.
33. Yamawaki, H. and Iwai, N. 2006. Cytotoxicity of water-soluble fullerene in vascular endothelial cells. Am. J. Physiol. Cell Physiol. 290: C1495-C1502.
34. Yamawaki, H., Pan, S., Lee, R. T. and Berk, B.C. 2005. Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells. J. Clin. Invest. 115: 733-738.
35. Yamawaki, H., Saito, K., Okada, M. and Hara, Y. 2008. Methylglyoxal mediates vascular inflammation via JNK and p38 in human endothelial cells. Am. J. Physiol. Cell Physiol. 295: C1510-C1517.
36. Youn, B. S., Klöting, N., Kratzsch, J., Lee, N., Park, J. W., Song, E. S., Ruschke, K., Oberbach, A., Fasshauer, M., Stumvoll, M. and Blüher, M. 2008. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 57: 372-377.
37. Zhou, Z., Connell, M. C. and MacEwan, D. J. 2007. TNFR1-induced NF-kappaB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells. Cell. Signal. 19: 1238-1248.
38. Zhou, Z., Gengaro, P., Wang, W., Wang, X. Q., Li, C., Faubel, S., Rivard, C. and Schrier, R. W. 2008. Role of NF-κB and PI 3-kinase/Akt in TNF-α-induced cytotoxicity in microvascular endothelial cells. Am. J. Physiol. Renal Physiol. 295: F932-F941.